NCT06213727View on ClinicalTrials.gov

ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

March 15, 2022

Primary Completion Date

November 14, 2022

Study Completion Date

November 14, 2022

Conditions
Corneal Epithelial Defect
Interventions
DRUG

lowe-dose ZKY001 eye drops

eye drops

DRUG

Medium-dose ZKY001 eye drops

eye drops

DRUG

ZKY001 simulated eye drops

eye drops

Trial Locations (1)

Unknown

Eye Hospital of Shandong First Medical University (Shandong Eye Hospital), Jinan

All Listed Sponsors
lead

Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.

INDUSTRY